Literature DB >> 18234500

Synthesis and screening of a cyclic peptide library: discovery of small-molecule ligands against human prolactin receptor.

Tao Liu1, Sang Hoon Joo, Jeffrey L Voorhees, Charles L Brooks, Dehua Pei.   

Abstract

Prolactin receptor is involved in normal lactation and reproduction; however, excessive prolactin levels can cause various reproductive disorders such as prolactinomas. Small-molecule antagonists against the human prolactin receptor (hPRLr) thus have potential clinical applications and may serve as useful molecular probes in biomedical research. In this work, we synthesized a large, support-bound cyclic peptide library (theoretical diversity of 1.2x10(7)) on 90-microm TentaGel beads and screened it against the extracellular domain of hPRLr. To facilitate hit identification, each TentaGel bead was spatially segregated into outer and inner layers, with a cyclic peptide displayed on the bead surface while the bead interior contained the corresponding linear peptide. The identity of a positive bead was revealed by sequencing the linear encoding peptide within the bead by partial Edman degradation/mass spectrometry. Screening of the library resulted in 20 hits, two of which were selected for further analysis and shown to bind to hPRLr with dissociation constants of 2-3 microM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18234500      PMCID: PMC2662701          DOI: 10.1016/j.bmc.2008.01.015

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  36 in total

Review 1.  Protein identification and analysis tools in the ExPASy server.

Authors:  M R Wilkins; E Gasteiger; A Bairoch; J C Sanchez; K L Williams; R D Appel; D F Hochstrasser
Journal:  Methods Mol Biol       Date:  1999

2.  A general route for post-translational cyclization of mRNA display libraries.

Authors:  Steven W Millward; Terry T Takahashi; Richard W Roberts
Journal:  J Am Chem Soc       Date:  2005-10-19       Impact factor: 15.419

3.  Decoding protein-protein interactions through combinatorial chemistry: sequence specificity of SHP-1, SHP-2, and SHIP SH2 domains.

Authors:  Michael C Sweeney; Anne-Sophie Wavreille; Junguk Park; Jonathan P Butchar; Susheela Tridandapani; Dehua Pei
Journal:  Biochemistry       Date:  2005-11-15       Impact factor: 3.162

4.  Genetically selected cyclic-peptide inhibitors of AICAR transformylase homodimerization.

Authors:  Ali Tavassoli; Stephen J Benkovic
Journal:  Angew Chem Int Ed Engl       Date:  2005-04-29       Impact factor: 15.336

Review 5.  Recent progress of the synthetic studies of biologically active marine cyclic peptides and depsipeptides.

Authors:  Yasumasa Hamada; Takayuki Shioiri
Journal:  Chem Rev       Date:  2005-12       Impact factor: 60.622

6.  De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria.

Authors:  Sylvie Monroc; Esther Badosa; Lidia Feliu; Marta Planas; Emili Montesinos; Eduard Bardají
Journal:  Peptides       Date:  2006-05-30       Impact factor: 3.750

7.  Highly selective cyclic peptide ligands for NeutrAvidin and avidin identified by phage display.

Authors:  Scott C Meyer; Thomas Gaj; Indraneel Ghosh
Journal:  Chem Biol Drug Des       Date:  2006-07       Impact factor: 2.817

8.  Traceless capping agent for peptide sequencing by partial edman degradation and mass spectrometry.

Authors:  Amit Thakkar; Anne-Sophie Wavreille; Dehua Pei
Journal:  Anal Chem       Date:  2006-08-15       Impact factor: 6.986

9.  High-throughput sequence determination of cyclic peptide library members by partial Edman degradation/mass spectrometry.

Authors:  Sang Hoon Joo; Qing Xiao; Yun Ling; Bhaskar Gopishetty; Dehua Pei
Journal:  J Am Chem Soc       Date:  2006-10-04       Impact factor: 15.419

10.  Combinatorial biosynthesis of novel antibiotics related to daptomycin.

Authors:  Kien T Nguyen; Daniel Ritz; Jian-Qiao Gu; Dylan Alexander; Min Chu; Vivian Miao; Paul Brian; Richard H Baltz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-07       Impact factor: 11.205

View more
  15 in total

1.  Machine learning assisted design of highly active peptides for drug discovery.

Authors:  Sébastien Giguère; François Laviolette; Mario Marchand; Denise Tremblay; Sylvain Moineau; Xinxia Liang; Éric Biron; Jacques Corbeil
Journal:  PLoS Comput Biol       Date:  2015-04-07       Impact factor: 4.475

2.  A Cleavable Scaffold Strategy for the Synthesis of One-Bead One-Compound Cyclic Peptoid Libraries That Can Be Sequenced By Tandem Mass Spectrometry.

Authors:  Levi S Simpson; Thomas Kodadek
Journal:  Tetrahedron Lett       Date:  2012-03-05       Impact factor: 2.415

3.  Asymmetric synthesis of vinylogous β-amino acids and their incorporation into mixed backbone oligomers.

Authors:  Hao Wu; Hongchan An; Shuting Cynthia Mo; Thomas Kodadek
Journal:  Org Biomol Chem       Date:  2017-04-11       Impact factor: 3.876

4.  Investigating fluorescent dyes in fluorescence-assisted screenings.

Authors:  Joo-Eun Jee; Jaehong Lim; Hoon Hyun; Jessica Oon; Yong Siang Ong; Cedrik Massif; Young-Tae Chang; Hak Soo Choi; Su Seong Lee
Journal:  Chem Commun (Camb)       Date:  2014-12-14       Impact factor: 6.222

5.  Membrane permeable cyclic peptidyl inhibitors against human Peptidylprolyl Isomerase Pin1.

Authors:  Tao Liu; Yu Liu; Hung-Ying Kao; Dehua Pei
Journal:  J Med Chem       Date:  2010-03-25       Impact factor: 7.446

Review 6.  Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.

Authors:  Eric M Jacobson; Eric R Hugo; Traci R Tuttle; Ruben Papoian; Nira Ben-Jonathan
Journal:  Trends Endocrinol Metab       Date:  2010-09-16       Impact factor: 12.015

7.  Synthesis of a large library of macrocyclic peptides containing multiple and diverse N-alkylated residues.

Authors:  Jumpei Morimoto; Thomas Kodadek
Journal:  Mol Biosyst       Date:  2015-10

8.  High-throughput screening of one-bead-one-compound libraries: identification of cyclic peptidyl inhibitors against calcineurin/NFAT interaction.

Authors:  Tao Liu; Ziqing Qian; Qing Xiao; Dehua Pei
Journal:  ACS Comb Sci       Date:  2011-08-26       Impact factor: 3.784

Review 9.  Expanding the number of 'druggable' targets: non-enzymes and protein-protein interactions.

Authors:  Leah N Makley; Jason E Gestwicki
Journal:  Chem Biol Drug Des       Date:  2013-01       Impact factor: 2.817

10.  Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.

Authors:  Prasad Dandawate; Gaurav Kaushik; Chandrayee Ghosh; David Standing; Afreen Asif Ali Sayed; Sonali Choudhury; Dharmalingam Subramaniam; Ann Manzardo; Tuhina Banerjee; Santimukul Santra; Prabhu Ramamoorthy; Merlin Butler; Subhash B Padhye; Joaquina Baranda; Anup Kasi; Weijing Sun; Ossama Tawfik; Domenico Coppola; Mokenge Malafa; Shahid Umar; Michael J Soares; Subhrajit Saha; Scott J Weir; Animesh Dhar; Roy A Jensen; Sufi Mary Thomas; Shrikant Anant
Journal:  Gastroenterology       Date:  2019-11-29       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.